Strategic partner for global clinical trials, RWE, and market access services

Written By Sabrina Müller

We are happy to announce that GIPAM has entered into a strategic partnership with Core Clinical Sciences (www.coreclinicalsciences.com). CCS’s expertise in simulation and modeling for clinical trials as well as advanced analytics solutions (external controls, QBA, transportability analysis, target trial emulation, Bayesian statistics, MCDA, and more) will naturally complement our expertise in Strategic Market Access Consulting and Real-World Evidence studies at GIPAM. This partnership will immensely strengthen our holistic service offerings and expand our global presence, especially in Europe and North America.

We look forward to many of our innovative research projects together as both of our companies grow together. More on new R&D soon!

We are more than happy to provide more details on the expanded capabilities – please feel free to reach out! 

 

More Articles

Sabrina Müller
Previous

How to finance innovative therapies in orphan indications?
Next

Recent G-BA assessment with substantial benefit!